Affinity DataKi: 0.139nMAssay Description:Inhibition of Escherichia coli BL21(DE3) Leucyl-tRNA synthetase assessed as reduction in tRNA aminoacylation preincubated for 10 mins with Escherichi...More data for this Ligand-Target Pair
Affinity DataKi: 0.654nMAssay Description:Inhibition of Escherichia coli BL21(DE3) Leucyl-tRNA synthetase assessed as reduction in tRNA aminoacylation preincubated for 10 mins with Escherichi...More data for this Ligand-Target Pair
Affinity DataKi: 2.5nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 5.5nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 9.80nMAssay Description:Inhibition of purified Escherichia coli BL21 (DE3) leuRS incubated for 10 mins in presence of 14C-labeled leucine by radiolabel transfer assayMore data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Inhibition of purified Escherichia coli BL21 (DE3) leuRS incubated for 10 mins in presence of 14C-labeled leucine by radiolabel transfer assayMore data for this Ligand-Target Pair
Affinity DataKi: 30nMAssay Description:Inhibition of purified Escherichia coli BL21 (DE3) leuRS incubated for 10 mins in presence of 14C-labeled leucine by radiolabel transfer assayMore data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 32nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 52nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 108nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 182nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 388nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
Affinity DataKi: 1.26E+3nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Saccharomyces cerevisiae S288c)
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 1.85E+3nMAssay Description:Inhibition of Saccharomyces cerevisiae cytoplasmic leucyl-tRNA synthetase after 20 minsMore data for this Ligand-Target Pair
Affinity DataKi: 2.97E+3nMAssay Description:Inhibition of recombinant Escherichia coli LeuRS assessed as inhibition of 14C-radiolabelled leucine transfer to tRNA leucine preincubated for 10 min...More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Saccharomyces cerevisiae S288c)
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataKi: 3.14E+4nMAssay Description:Inhibition of Saccharomyces cerevisiae cytoplasmic leucyl-tRNA synthetase after 2 minsMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Staphylococcus aureus (strain NCTC 8325))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of Staphylococcus aureus LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 1.60nMAssay Description:Compound tested for the inhibition of E. coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Staphylococcus aureus (strain NCTC 8325))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 1.70nMAssay Description:Inhibition of Staphylococcus aureus LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Compound tested for the inhibition of E. coli Leucyl-tRNA synthetaseMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Staphylococcus aureus (strain NCTC 8325))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 2.70nMAssay Description:Inhibition of Staphylococcus aureus LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 3.40nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Staphylococcus aureus (strain NCTC 8325))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 3.60nMAssay Description:Inhibition of Staphylococcus aureus LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 3.90nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Staphylococcus aureus (strain NCTC 8325))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 4.40nMAssay Description:Inhibition of Staphylococcus aureus LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Staphylococcus aureus (strain NCTC 8325))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 5.40nMAssay Description:Inhibition of Staphylococcus aureus LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Compound tested for the inhibition of human isoleucyl-tRNA synthetaseMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Staphylococcus aureus (strain NCTC 8325))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 9.20nMAssay Description:Inhibition of Staphylococcus aureus LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 16nMAssay Description:Compound was evaluated for its inhibitory activity against Leucyl-tRNA synthetase from staphylococcus aureus WCUH29More data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 22nMAssay Description:Inhibition of catalytic activity of LRS (unknown origin) by aminoleucylation assayMore data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 33nMAssay Description:Inhibition of human LeuRS assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
Affinity DataIC50: 35nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of Mycobacterium tuberculosis H37Rv N-terminal 6His-tagged LeuRS expressed in Escherichia coli BL21(DE3) assessed as L-[14C]leucine incorp...More data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
Affinity DataIC50: 54nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 56nMAssay Description:Binding affinity against sigma receptor from guinea pig brain, using [3H](+)-3-PPP as radioligand.More data for this Ligand-Target Pair
Affinity DataIC50: 65nMAssay Description:Inhibition of Escherichia coli LeuRS expressed in Escherichia coli M15 cells assessed as reduction in ATP consumptionMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase, cytoplasmic(Homo sapiens (Human))
Oxford Drug Design Ltd.
Curated by ChEMBL
Oxford Drug Design Ltd.
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of catalytic activity of LRS (unknown origin) by aminoleucylation assayMore data for this Ligand-Target Pair
TargetLeucine--tRNA ligase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Anacor Pharmaceuticals Inc
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibition of Mycobacterium tuberculosis H37Rv N-terminal 6His-tagged LeuRS expressed in Escherichia coli BL21(DE3) assessed as L-[14C]leucine incorp...More data for this Ligand-Target Pair
